MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. (INKT) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 86 transactions totaling $17.7M, demonstrating a bullish sentiment with $17.5M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 50,000 shares valued at $0.
INKT Insider Activity Summary
Who Is Buying INKT Stock?
No significant insider buying has been recorded for INKT in the recent period.
Who Is Selling INKT Stock?
No significant insider selling has been recorded for INKT in the recent period.
Is MiNK Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INKT is bullish with an Insider Alignment Score of 99/100 and a net flow of $17.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
INKT Frequently Asked Questions
Understanding INKT Insider Activity
Insider trading at MiNK Therapeutics, Inc. (INKT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading INKT stock, having executed 86 transactions in the past 90 days. The most active insider is Inc Agenus (Executive), who has made 17 transactions totaling $17.5M.
Related Tools
Track MiNK Therapeutics, Inc. Insider Activity
Get notified when executives and directors at INKT file new Form 4 transactions